Summary & Overview
CPT 0263T: Autologous Bone Marrow Harvest and Intramuscular Injection for PAD
Headline: New CPT code 0263T covers autologous bone marrow harvest, preparation, and intramuscular injection for advanced peripheral artery disease
Lead: CPT code 0263T denotes a biologic cellular therapy procedure that involves harvesting a patient’s bone marrow, preparing the aspirate, and administering it by intramuscular injection to treat conditions such as end-stage peripheral artery disease. The code reflects growing clinical interest in regenerative and cell-based vascular therapies and has implications for coverage, site-of-service planning, and coding compliance.
Why it matters: This code captures a complex, resource-intensive intervention that combines operative harvest and therapeutic injection. Nationally, payers are assessing clinical evidence, appropriate settings of care, and coding guidance for similar autologous cell therapies, making accurate use of this code important for billing integrity and utilization tracking.
Payers covered: The analysis includes major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: The publication provides benchmarks and contextual policy discussion for CPT code 0263T, outlines typical sites of service and service type, summarizes payer coverage patterns where available, and explains clinical context for use in patients with advanced peripheral artery disease. It also notes where input data are unavailable and identifies areas requiring further payer-specific policy review.
Billing Code Overview
CPT code 0263T describes a procedure in which a provider extracts bone marrow from the patient, processes or prepares the aspirate, and injects the prepared bone marrow into the patient's muscles to treat conditions such as end-stage peripheral artery disease. The service type is a biologic cellular therapy delivered via injection. The typical site of service is an outpatient surgical or procedure suite, ambulatory surgical center, or specialized interventional clinic that can perform bone marrow harvest and intramuscular injections.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old male with end-stage peripheral artery disease (PAD) who has ischemic rest pain and nonhealing ischemic ulcers of the lower extremity despite maximal medical therapy, smoking cessation efforts, and prior endovascular or surgical revascularization attempts. The vascular surgeon or interventional pain/vascular specialist evaluates the patient in an outpatient or ambulatory surgery center setting and documents vascular exam (absent or diminished distal pulses), noninvasive testing (ankle-brachial index, toe pressures), and wound assessment. After multidisciplinary review and informed consent, the provider schedules an autologous bone marrow aspiration, point-of-care processing to concentrate progenitor cells, and intramuscular injection of the prepared marrow into ischemic limb musculature to promote angiogenesis. Typical site of service is an outpatient ambulatory surgery center or hospital outpatient department; the procedure may include local anesthesia with monitored anesthesia care or general anesthesia depending on patient condition and provider preference. Postprocedure monitoring includes vital signs, limb neurovascular checks, wound care instructions, and follow-up vascular imaging and clinic visits to assess pain, perfusion, and wound healing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Standard procedure indicator (no modifier) | Rarely reported as a modifier; use the appropriate CMS default when no specific modifier applies. |
| 22 | Increased procedural services | Use when services required substantially greater effort, time, or complexity than typical for intramuscular bone marrow injection. |
| 23 | Unusual anesthesia | Use when general anesthesia is required for circumstances where local/regional anesthesia would normally be expected. |
| 52 | Reduced services | Use when the procedure is partially reduced or not completed as originally planned but still performed. |
| 53 | Discontinued procedure | Use when the procedure is terminated due to patient condition or other extenuating circumstances before completion. |
| 62 | Two surgeons | Use when two surgeons with different specialties are required to perform distinct portions of the procedure. |
| 66 | Surgical team | Use when a surgical team approach is documented as necessary for portions of the procedure. |
| 78 | Unplanned return to operating/procedure room by same physician following initial procedure for a related procedure during the postoperative period | Use when the patient requires an unplanned repeat intramuscular injection or related operative intervention during the global period. |
| 80 | Assistant surgeon | Use when an assistant surgeon is documented and billed for assisting with aspiration, processing, or injection steps. |
| 81 | Minimum assistant surgeon | Use when the assistant surgeon role meets minimum criteria per payer policy. |
| 82 | Assistant surgeon (when a qualified resident is not available) | Use when an assistant surgeon is required and no resident is available. |
| AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery | Use when an advanced practice clinician acts as the documented assistant during the procedure per payer rules. |
| QK | Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals | Use when the physician directs multiple concurrent anesthesia services during this procedure. |
| QX | CRNA service: CRNA with medical direction by physician | Use when a CRNA provides anesthesia under physician direction during the procedure. |
| QY | Medical direction of one certified registered nurse anesthetist (CRNA) by an anesthesiologist | Use when an anesthesiologist medically directs a CRNA for this procedure. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
2080S0004X | Vascular Surgery | Vascular surgeons commonly perform limb salvage procedures including bone marrow cell therapies. |
207T00000X | Interventional Cardiology/Vascular Interventional | Interventional specialists who perform limb-based therapies and endovascular care. |
2086S0122X | Pain Medicine | Interventional pain specialists may perform intramuscular cell injections as part of limb ischemia treatment. |
207L00000X | Orthopedic Surgery | Orthopedic surgeons with limb salvage expertise may be involved in aspiration/ injection procedures. |
363L00000X | Hematology (procedural involvement) | Hematology specialists may be involved with bone marrow aspiration or processing protocols. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
I70.23 | Atherosclerosis of native arteries of extremities with ulceration, bilateral legs | Represents advanced PAD with tissue loss often considered for limb salvage therapies including autologous bone marrow cell injections. |
| I70.24 | Atherosclerosis of native arteries of extremities with gangrene, bilateral legs | Advanced ischemia with gangrene indicating severe limb threat where adjunctive cell therapy may be considered. |
| I70.201 | Atherosclerosis of native arteries of extremities with intermittent claudication, right leg | Claudication is an earlier PAD manifestation; some patients progress to critical limb ischemia and require advanced therapies. |
| I70.22 | Atherosclerosis of native arteries of extremities with ulceration, left leg | Unhealed ulcers from PAD are a primary indication for limb salvage interventions. |
| I96 | Gangrene, not elsewhere classified | Clinical descriptor used when gangrene is present and may be used with PAD codes in limb-threatening ischemia. |
| L97.421 | Non-pressure chronic ulcer of left lower leg limited to breakdown of skin | Describes chronic ulceration location and severity relevant for documenting wound status before cell therapy. |
| L97.423 | Non-pressure chronic ulcer of left lower leg with fat layer exposed | Indicates deeper tissue involvement supporting advanced limb preservation strategies. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
0263T | Injection(s), vascular tissue; implantation of autologous concentrated bone marrow derived cells (including aspiration and processing) for therapeutic purposes | Primary procedure code describing aspiration, preparation, and intramuscular injection of autologous bone marrow for peripheral artery disease. |
| 38220 | Bone marrow aspiration, any technique, any site, or bone marrow biopsy, needle or trocar | May be reported when a separate or additional bone marrow aspiration is performed and documentation supports distinct reporting from the processing/injection service. |
| 36415 | Collection of venous blood by venipuncture | Used for required preprocedure laboratory testing such as CBC, coagulation studies drawn on the day of or before procedure. |
| 95930 | Motor and/or sensory nerve conduction; amplitude and latency/velocity study, 1 nerve, 2 studies | Used when neurovascular baseline testing is performed as part of limb assessment (example ancillary diagnostics). |
| 99152 | Moderate sedation services provided by the same physician/other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, initial 15 minutes intra-service time | Billed when moderate sedation is furnished by the same provider performing the procedure per payer rules. |
| 99153 | Each additional 15 minutes of moderate sedation provided by same physician/other qualified health care professional | Billed in conjunction with initial moderate sedation code when additional time is documented. |